Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pacific Biosciences of California, Inc. PACB

Full chart Compare
Set alert

Price alert · PACB

All alert types
2.43 USD -0.12 (-4.71%)

At closeNov 6, 2026, 6:03 AM EST

2.43 0.00 0.00%

Pre-market · Nov 6, 6:03 AM ET

2.23 Day range 2.69
1.07 52-week range 3.44
YTD
+29.95%
1 year
+36.52%

Financial health

Altman Z-Score

-4.63 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.0×
FY 2016: -4.6×FY 2017: -3.0×FY 2018: -9.7×FY 2019: -10.1×FY 2020: 144×FY 2021: -23.0×FY 2022: -5.8×FY 2023: -8.1×FY 2024: -1.6×FY 2025: -1.0×
FY 2016 5y median -5.8× FY 2025
P/S 3.5×
FY 2016: 3.7×FY 2017: 3.0×FY 2018: 12.7×FY 2019: 8.6×FY 2020: 54.3×FY 2021: 31.9×FY 2022: 14.3×FY 2023: 12.4×FY 2024: 3.3×FY 2025: 3.5×
FY 2016 5y median 12.4× FY 2025
P/B 105×
FY 2016: 4.0×FY 2017: 3.2×FY 2018: 8.8×FY 2019: 14.3×FY 2020: 12.8×FY 2021: 5.3×FY 2022: 3.3×FY 2023: 3.5×FY 2024: 1.0×FY 2025: 105×
FY 2016 5y median 3.5× FY 2025
P/FCF -4.9×
FY 2016: -4.4×FY 2017: -3.6×FY 2018: -14.6×FY 2019: -9.7×FY 2020: 232×FY 2021: -35.6×FY 2022: -6.6×FY 2023: -9.0×FY 2024: -2.4×FY 2025: -4.9×
FY 2016 5y median -6.6× FY 2025
EV/EBITDA -8.2×
FY 2016: -5.0×FY 2017: -2.8×FY 2018: -10.7×FY 2019: -11.4×FY 2020: 109×FY 2021: -18.6×FY 2022: -8.7×FY 2023: -12.0×FY 2024: -4.6×FY 2025: -8.2×
FY 2016 5y median -8.7× FY 2025
EV/Sales 7.9×
FY 2016: 3.7×FY 2017: 2.5×FY 2018: 12.6×FY 2019: 9.0×FY 2020: 53.8×FY 2021: 35.7×FY 2022: 19.2×FY 2023: 16.2×FY 2024: 7.3×FY 2025: 7.9×
FY 2016 5y median 16.2× FY 2025
FCF Yield -20.3%
FY 2016: -22.5%FY 2017: -27.9%FY 2018: -6.8%FY 2019: -10.4%FY 2020: 0.4%FY 2021: -2.8%FY 2022: -15.3%FY 2023: -11.1%FY 2024: -42.3%FY 2025: -20.3%
FY 2016 5y median -15.3% FY 2025

Profitability

Gross Margin 31.7%
FY 2016: 48.7%FY 2017: 37.1%FY 2018: 31.9%FY 2019: 38.0%FY 2020: 41.3%FY 2021: 45.1%FY 2022: 38.2%FY 2023: 26.3%FY 2024: 24.2%FY 2025: 31.7%
FY 2016 5y median 31.7% FY 2025
Operating Margin -348.5%
FY 2016: -78.5%FY 2017: -96.1%FY 2018: -128.4%FY 2019: -110.6%FY 2020: -132.3%FY 2021: -161.2%FY 2022: -239.4%FY 2023: -166.8%FY 2024: -308.0%FY 2025: -348.5%
FY 2016 5y median -239.4% FY 2025
Net Margin -341.5%
FY 2016: -82.0%FY 2017: -98.6%FY 2018: -130.4%FY 2019: -92.6%FY 2020: 37.3%FY 2021: -138.9%FY 2022: -244.9%FY 2023: -153.0%FY 2024: -201.2%FY 2025: -341.5%
FY 2016 5y median -201.2% FY 2025
ROE -10214.5%
FY 2016: -87.8%FY 2017: -107.1%FY 2018: -89.9%FY 2019: -153.2%FY 2020: 8.8%FY 2021: -22.9%FY 2022: -55.8%FY 2023: -43.7%FY 2024: -61.2%FY 2025: -10214.5%
FY 2016 5y median -55.8% FY 2025
ROIC -76.4%
FY 2016: -68.4%FY 2017: -73.7%FY 2018: -67.4%FY 2019: -84.8%FY 2020: -27.5%FY 2021: -7.1%FY 2022: -20.3%FY 2023: -19.4%FY 2024: -39.4%FY 2025: -76.4%
FY 2016 5y median -20.3% FY 2025
ROA -69.7%
FY 2016: -53.9%FY 2017: -64.0%FY 2018: -60.2%FY 2019: -56.9%FY 2020: 7.1%FY 2021: -9.0%FY 2022: -17.8%FY 2023: -17.6%FY 2024: -24.6%FY 2025: -69.7%
FY 2016 5y median -17.8% FY 2025

Growth (YoY)

Revenue 3.9%
FY 2016: -2.2%FY 2017: 3.0%FY 2018: -15.9%FY 2019: 15.6%FY 2020: -13.2%FY 2021: 65.4%FY 2022: -1.7%FY 2023: 56.3%FY 2024: -23.2%FY 2025: 3.9%
FY 2016 FY 2025
Operating Income -17.6%
FY 2016: -144.5%FY 2017: -26.0%FY 2018: -12.5%FY 2019: 0.4%FY 2020: -3.8%FY 2021: -101.6%FY 2022: -46.0%FY 2023: -8.9%FY 2024: -41.8%FY 2025: -17.6%
FY 2016 FY 2025
EPS (diluted) -70.1%
FY 2016: -97.6%FY 2017: -4.8%FY 2018: 12.6%FY 2019: 32.9%FY 2020: 133.3%FY 2021: -623.5%FY 2022: -57.3%FY 2023: 13.6%FY 2024: 11.6%FY 2025: -70.1%
FY 2016 FY 2025
Free Cash Flow 46.3%
FY 2016: -49.6%FY 2017: -2.4%FY 2018: 12.4%FY 2019: -18.8%FY 2020: 122.8%FY 2021: -734.3%FY 2022: -139.2%FY 2023: 1.7%FY 2024: 22.9%FY 2025: 46.3%
FY 2016 FY 2025

Financial Health

Current Ratio 6.9×
FY 2016: 3.2×FY 2017: 4.6×FY 2018: 6.5×FY 2019: 1.6×FY 2020: 9.2×FY 2021: 15.4×FY 2022: 3.2×FY 2023: 7.8×FY 2024: 7.5×FY 2025: 6.9×
FY 2016 5y median 7.5× FY 2025
Quick Ratio 6.0×
FY 2016: 2.8×FY 2017: 3.5×FY 2018: 5.6×FY 2019: 1.4×FY 2020: 8.9×FY 2021: 15.0×FY 2022: 3.0×FY 2023: 7.2×FY 2024: 6.6×FY 2025: 6.0×
FY 2016 5y median 6.6× FY 2025
Debt / Equity 142×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 1.1×FY 2020: 0.1×FY 2021: 1.2×FY 2022: 1.7×FY 2023: 1.3×FY 2024: 1.3×FY 2025: 142×
FY 2016 5y median 1.3× FY 2025
Net Debt / EBITDA -4.6×
FY 2016: 0.0×FY 2017: 0.6×FY 2018: 0.0×FY 2019: -0.4×FY 2020: -1.0×FY 2021: -2.0×FY 2022: -2.2×FY 2023: -2.8×FY 2024: -2.5×FY 2025: -4.6×
FY 2016 5y median -2.5× FY 2025
Interest Coverage -80.2×
FY 2016: -22.0×FY 2017: -30.7×FY 2018: -41.7×FY 2019: -38.5×FY 2020: -391×FY 2021: -16.8×FY 2022: -20.9×FY 2023: -23.3×FY 2024: -35.4×FY 2025: -80.2×
FY 2016 5y median -23.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31